Circulating monocytes are not the major source of plasma cytokines in patients with sepsis

Shock

Volumn 38, Issue 6, 2012, Pages 577-583

  Gille Johnson, Patrik ^a   Smedman, Christian ^a,b   Gudmundsdotter, Lindvi ^b   Somell, Anna ^a   Nihlmark, Kopek ^b   Paulie, Staffan ^b   Andersson, Jan ^a   Gårdlund, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Mabtech AB ^*  (Sweden)

Author keywords

Bacteremia; critical care; cytokines; enzyme linked immunospot assay; immunity; innate; leukocytes; septic; shock

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MONOCYTE; OBSERVATIONAL STUDY; PLASMA; PNEUMONIA; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RATING SCALE; RECEPTOR DOWN REGULATION; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; CYTOKINES; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; PLASMA; PROSPECTIVE STUDIES; SEPSIS;

EID: 84870053565     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182746e52     Document Type: Article

References (37)

1. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D: Cytokine cascade in sepsis. Scand J Infect Dis 35(9):535-544, 2003. (Pubitemid 37336870)
2. Cohen J: The immunopathogenesis of sepsis. Nature 420(6917):885-891, 2002. (Pubitemid 36019643)
3. Cavaillon J-M, Adrie C, Fitting C, Adib-Conquy M: Reprogramming of circulatory cells in sepsis and SIRS. J Endotoxin Res 11(5):311-320, 2005. (Pubitemid 41556040)
4. Bone RC, Grodzin CJ, Balk RA: Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112(1):235-243, 1997. (Pubitemid 27343624)
5. Volk HD, Reinke P, Krausch D, Zuckermann H, Asadullah K, Muller JM, Döcke W-D, Kox WJ: Monocyte deactivationYrationale for a new therapeutic strategy in sepsis. Intensive Care Med 22(Suppl 4):S474-S481, 1996. (Pubitemid 26370899)
6. Rogy MA, Oldenburg HS, Coyle S, Trousdale R, Moldawer LL, Lowry SF: Correlation between Acute Physiology and Chronic Health Evaluation (APACHE) III score and immunological parameters in critically ill patients with sepsis. Br J Surg 83(3):396-400, 1996.
7. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644-1655, 1992.
8. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31(4):1250-1256, 2003. (Pubitemid 36444440)
9. Smedman C, Gardlund B, Nihlmark K, Gille-Johnson P, Andersson J, Paulie S: ELISpot analysis of LPS-stimulated leukocytes: human granulocytes selectively secrete IL-8, MIP-1beta and TNF-alpha. J Immunol Methods 346(1-2): 1-8, 2009.
10. Schroder AK, von der Ohe M, Kolling U, Altstaedt J, Uciechowski P, Fleischer D, Dalhoff K, Ju X, Zenke M, Heussen N, et al.: Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 receptor antagonist and chemokines, but fail to produce pro-inflammatory mediators. Immunology 119(3):317-327, 2006. (Pubitemid 44571049)
11. Bjork L, Andersson J, Ceska M, Andersson U: Endotoxin and Staphylococcus aureus enterotoxin A induce different patterns of cytokines. Cytokine 4(6): 513-519, 1992.
12. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC: The use of geneexpression profiling to identify candidate genes in human sepsis. Am J Respir Crit Care Med 176:676-684, 2007. (Pubitemid 47503075)
13. Tang BM, McLean AS, Dawes IW, Huang SJ, Cowley MJ, Lin RC: Geneexpression profiling of gram-positive and gram-negative sepsis in critically ill patients. Crit Care Med 36:1125-1128, 2008. (Pubitemid 351482660)
14. Ertel W, Kremer J, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW: Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85(5):1341-1347, 1995.
15. Tsujimoto H, Ono S, Majima T, Efron PA, Kinoshita M, Hiraide H, Moldawer LL, Mochizuki H: Differential Toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress. Clin Immunol 119(2):180-187, 2006.
16. Sfeir T, Saha DC, Astiz M, Rackow EC: Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med 29(1): 129-133, 2001. (Pubitemid 32125786)
17. Fumeaux T, Dufour J, Stern S, Pugin J: Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines. Intensive Care Med 30(11):2028-2037, 2004. (Pubitemid 40022318)
18. Munoz C, Misset B, Fitting C, Blériot J-P, Jean C, Cavaillon J-M: Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J Immunol 21(9):2177-2184, 1991.
19. Hotta N, Ichiyama T, Shiraishi M, Takekawa T, Matsubara T, Furukawa S: Nuclear factor-kappaB activation in peripheral blood mononuclear cells in children with sepsis. Crit Care Med 35(10):2395-2401, 2007. (Pubitemid 47476240)
20. Tang BM, Huang SJ, McLean AS: Genome-wide transcription profiling of human sepsis: a systematic review. Crit Care 14(6):R237, 2010.
21. Guo Y, Xiao P, Lei S, Deng F, Xiao GG, Liu Y, Chen X, Li L,Wu S, Chen Y, et al.: How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin (Shanghai) 40(5):426-436, 2008. (Pubitemid 351704046)
22. Kamei M, Carman CV: New observations on the trafficking and diapedesis of monocytes. Curr Opin Hematol 17(1):43-52, 2010.
23. Mayr FB, Firbas C, Leitner JM, Spiel AO, Reiter RA, Beyer D, Meyer M, Wolff G, Jilma B: Effects of the pan-selectin antagonist bimosiamose (TBC1269) in experimental human endotoxemia. Shock 29(4):475-482, 2008. (Pubitemid 351416801)
24. Krabbe KS, Bruunsgaard H, Hansen CM, Moller K, Fonsmark L, Qvist J, Madsen PL, Kronborg G, Andersen HO, Skinhoj P, et al.: Ageing is associated with a prolonged fever response in human endotoxemia. Clin Diagn Lab Immunol 8(2):333-338, 2001. (Pubitemid 32218715)
25. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM: Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88(5):1747-1754, 1991.
26. Biswas SK, Lopez-Collazo E: Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 30(10):475-487, 2009.
27. Kox MM, de Kleijn SM, Pompe JC, Ramakers BP, Netea MG, van der Hoeven JG, Hoedemaekers CW, Pickkers P: Differential ex vivo and in vivo endotoxin tolerance kinetics following human endotoxemia. Crit Care Med 39(8):1866-1870, 2011.
28. Poehlmann H, Schefold JC, Zuckermann-Becker H, Volk HD, Meisel C: Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis. Crit Care 13:R119, 2009.
29. Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Denny T, Deitch EA: Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward TH2-type lymphocyte pattern in severely injured male trauma patients. Crit Care Med 31(6):1722-1729, 2003. (Pubitemid 36714228)
30. Lion E, Smits EL, Berneman ZN, Van Tendeloo VF: Quantification of IFNgamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays. J Immunol Methods 350:89-96, 2009.
31. Adib-Conquy M, Adrie C, Fitting C, Gattolliat O, Beyaert R, Cavaillon JM: Upregulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients. Crit Care Med 34(9):2377-2385, 2006. (Pubitemid 44260023)
32. Rigato O, Salomao R: Impaired production of interferon-gamma and tumor necrosis factor-alpha but not of interleukin 10 in whole blood of patients with sepsis. Shock 19(2):113-116, 2003.
33. Cavaillon JM, Adib-Conquy M: Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 10(5):233, 2006.
34. Monneret G, Venet F, Pachot A, Lepape A: Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 14(1-2):64-78, 2008. (Pubitemid 351356886)
35. Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, Volk HD: Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med 181(5):1887-1892, 1995.
36. Haupt W, Zirngibl H, Stehr A, Riese J, Holzheimer RG, Hohenberger W: Tumour necrosis factor-alpha and interleukin-10 production in septic patients and the regulatory effect of plasma. Eur J Surg 165(2):95-100, 1999. (Pubitemid 29381742)
37. Carlet J, Cohen J, Calandra T, Opal SM, Masur H: Sepsis: time to reconsider the concept. Crit Care Med 36(3):964-966, 2008.